Europe — EMA

Omesar (Olmesartan Medoxomil)

Olmesartan medoxomil, the active ingredient in Omesar, is an Angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It is indicated for the management of hypertension in adults.

Olmesartan Medoxomil

Request sourcing

Pack/s

What is Olmesartan Medoxomil?

Olmesartan medoxomil, the active ingredient in Omesar, is an Angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It is indicated for the management of hypertension in adults. GNH USA supplies Omesar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omesar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Olmesartan Medoxomil used for?

Omesar is an ARB that treats conditions related to the renin‑angiotensin system.

- Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Heart failure: improves symptoms and may reduce hospitalisation when used with standard therapy. - Diabetic nephropathy: slows progression of kidney damage in patients with type 2 diabetes.

What are the side effects of Olmesartan Medoxomil?

Olmesdel .... .... .... ... .... .... ...

What precautions apply to Olmesartan Medoxomil?

...

What does Olmesartan Medoxomil interact with?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →